Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International Immunocancer Registry (ICIR)

Medicine & Life Sciences

• Sjogren's Syndrome 100%
• Registries 69%
• Sialadenitis 18%
• Immunotherapy 11%
• durvalumab 10%
• Cryoglobulins 9%
• pembrolizumab 8%
• Nivolumab 8%
• Big Data 8%
• Neoplasms 8%
• Dry Eye Syndromes 7%
• Information Dissemination 7%
• Allergy and Immunology 6%
• Internal Medicine 6%
• Routine Diagnostic Tests 5%
• Glucocorticoids 5%
• Mouth 5%
• Melanoma 5%
• Lung Neoplasms 4%
• Therapeutics 4%
• Eye 3%
• Biopsy 3%
• Kidney 3%